At a glance
Key figures (IFRS) |
|||||
|
|
|
|
||
Galapagos group (in € thousands, if not stated otherwise) |
31/12/2016 |
31/12/2015 |
31/12/2014 |
||
|
|||||
Results1 |
|
|
|
||
Revenues and other income |
151,612 |
60,579 |
90,021 |
||
R&D expenditure |
(139,573) |
(129,714) |
(111,110) |
||
S, G&A expenses |
(23,530) |
(20,308) |
(14,867) |
||
Restructuring and integration costs |
– |
– |
(669) |
||
Personnel expenses (including share-based compensation) |
(53,530) |
(47,034) |
(38,447) |
||
Capital expenditure |
4,790 |
6,665 |
2,804 |
||
Depreciation and amortization of (in)tangible assets |
(4,182) |
(3,402) |
(3,765) |
||
Operating loss |
(11,491) |
(89,444) |
(36,624) |
||
Net financial results |
65,737 |
(30,184) |
1,424 |
||
Taxes |
(235) |
1,218 |
(2,103) |
||
Net income / loss (–) from continuing operations |
54,012 |
(118,410) |
(37,303) |
||
Net income from discontinued operations |
– |
– |
70,514 |
||
Net income / loss (–) |
54,012 |
(118,410) |
33,211 |
||
Balance sheet |
|
|
|
||
Total assets |
1,083,338 |
442,514 |
270,467 |
||
Cash, cash equivalents and restricted cash |
980,909 |
348,216 |
198,440 |
||
Total liabilities |
324,637 |
77,515 |
64,332 |
||
Stockholders’ equity |
758,701 |
364,999 |
206,135 |
||
Galapagos share |
|
|
|
||
Number of shares issued on 31 December |
46,256,078 |
39,076,342 |
30,299,129 |
||
Basic income / loss (–) per share (in €) |
1.18 |
(3.32) |
1.10 |
||
Diluted income / loss (–) per share (in €) |
1.14 |
(3.32) |
1.10 |
||
Share price on 31 December (in €) |
60.94 |
56.76 |
15.49 |
||
Personnel data |
|
|
|
||
Total group employees on 31 December (number) |
508 |
435 |
417 |
Employees per site
Number of R&D employees1
1 Total Galapagos R&D (Mechelen, Leiden, Romainville), including external consultants. Total head count Galapagos group (Galapagos R&D and Fidelta) including external consultants amounts to 508.